Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

Clayton Anita H.; Tourian Karen A.; Focht Kristen; Hwang Eunhee; Cheng Ru-fong J.; Thase Michael E.

首页> 外文期刊>The journal of clinical psychiatry >Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

【24h】

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

机译：Desvenlafaxine 50和100 mg / d与安慰剂相比，用于治疗重度抑郁症：第4期，随机对照试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess short-term efficacy and safety of desvenlafaxine 50 and 100 mg/d versus placebo for treating major depressive disorder (MDD). Assessment of sexual function was a secondary objective.

机译：目的：评估地塞拉法辛50和100 mg / d相对于安慰剂治疗严重抑郁症（MDD）的近期疗效和安全性。评估性功能是次要目标。

著录项

来源
《The journal of clinical psychiatry》 |2015年第5期|共8页
作者
Clayton Anita H.; Tourian Karen A.; Focht Kristen; Hwang Eunhee; Cheng Ru-fong J.; Thase Michael E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial [J] . Clayton Anita H., Tourian Karen A., Focht Kristen, The journal of clinical psychiatry . 2015,第5期

机译：Desvenlafaxine 50和100 mg / d与安慰剂相比，用于治疗重度抑郁症：第4期，随机对照试验
2. Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial [J] . Anita H. Clayton, Eunhee Hwang, Karen A. Tourian, Primary care companion to the journal of clinical psychiatry . 2014,第5期

机译：Desvenlafaxine 50和100 mg / d与安慰剂相比，用于治疗重度抑郁症：第4期，随机对照试验
3. Desvenlafaxine 50 and 100 mg/d in the Treatment of Major Depressive Disorder: An 8-Week, Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial and a Post Hoc Pooled Analysis of Three Studies [J] . Alison J. Cousins Clinical therapeutics . 2009,第Pta1期

机译：Desvenlafaxine 50和100 mg / d用于治疗重度抑郁症：8周，III期，多中心，随机，双盲，安慰剂对照，平行组试验和三项研究的事后汇总分析
4. A randomized placebo-controlled trial of low-dose monophasic pills in the treatment of functional ovarian cysts [C] . World Congress on Fertility and Sterility . 2004

机译：低剂量单体丸治疗功能性卵巢囊肿的随机安慰剂对照试验
5. A Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Effect of Intranasal Insulin on Cognition and Emotional Processing in Individuals with Treatment-Resistant Major Depressive Disorder. [D] . Cha, Danielle Soh-Young. 2016

机译：一项随机，双盲，安慰剂对照的交叉试验评估了鼻内胰岛素对难治性重度抑郁症患者认知和情绪加工的影响。
6. Efficacy of Desvenlafaxine 50 mg/d Versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized Double-Blind Trial [O] . Patrice Boyer, Cécile Vialet, Eunhee Hwang, 2015

机译：Desvenlafaxine 50 mg / d与安慰剂对长期治疗重大抑郁症的疗效：一项随机双盲试验
7. A double-blind, randomized, placebo-controlled study assessing the efficacy and tolerability of desvenlafaxine 10 and 50 mg/day in adult outpatients with major depressive disorder [O] . Michael R Liebowitz, null null, Karen A Tourian, 2013

机译：一项双盲，随机，安慰剂对照研究，评估desvenlafaxine 10和50 mg /天在患有重度抑郁症的成人门诊患者中的疗效和耐受性

Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial

摘要

著录项

相似文献

相关主题

期刊订阅